M
IMEPro
F33.1 Psychiatric
Updated March 2026

Major depressive disorder, recurrent, moderate

ICD-10 Code: F33.1 · Body Part: Head/Brain (TBI)

QME Evaluation Process

Psychiatric interview, PHQ-9, treatment history review, functional assessment. Chapter 14 impairment. Apportionment for pre-existing depression vs industrial aggravation.

Typical Impairment Rating

15-35% WPI with apportionment

AMA Guides Edition

5th Edition

Common Treatments

+ Maintenance psychotherapy
+ Long-term medication management
+ CBT

Related Conditions

Body Part Guide

Head/Brain (TBI) Evaluation Guide

Impairment rating methods, common conditions, and QME evaluation protocols

View Guide →

QME Specialties for Major depressive disorder, recurrent, moderate

Find a QME Specialist

Browse QME-certified physicians who evaluate major depressive disorder, recurrent, moderate and related head/brain (tbi) conditions in California.

Browse Neurology Physicians →

Frequently Asked Questions

What is Major depressive disorder, recurrent, moderate (F33.1)?

Major depressive disorder, recurrent, moderate is an ICD-10 diagnosis code (F33.1) classified under Psychiatric conditions. It affects the Head/Brain (TBI) and is commonly encountered in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.

How is F33.1 rated for impairment?

The typical whole person impairment (WPI) range for Major depressive disorder, recurrent, moderate is 15-35% WPI with apportionment. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.

What is the QME evaluation process for F33.1?

Psychiatric interview, PHQ-9, treatment history review, functional assessment. Chapter 14 impairment. Apportionment for pre-existing depression vs industrial aggravation.

What treatments are common for Major depressive disorder, recurrent, moderate?

Common treatments for Major depressive disorder, recurrent, moderate include Maintenance psychotherapy, Long-term medication management, CBT. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.